The global market for Treatment and Prevention of Herpes Labialis was valued at US$ 1291 million in the year 2024 and is projected to reach a revised size of US$ 1715 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Treatment and Prevention of Herpes Labialis Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Treatment and Prevention of Herpes Labialis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment and Prevention of Herpes Labialis.

The Treatment and Prevention of Herpes Labialis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Treatment and Prevention of Herpes Labialis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Treatment and Prevention of Herpes Labialis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Treatment and Prevention of Herpes Labialis Market Report

Report Metric	Details
Report Name	Treatment and Prevention of Herpes Labialis Market
Accounted market size in year	US$ 1291 million
Forecasted market size in 2031	US$ 1715 million
CAGR	4.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Valacyclovir Aciclovir Famciclovir Docosanol Other
Segment by Application	External Use Oral Injection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Luoxin, Med shine, Bayer(Campho Phenique), Blistex, Kelun Group, Hikma, Haiwang, Carmex, Cipher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Treatment and Prevention of Herpes Labialis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Treatment and Prevention of Herpes Labialis Market growing?

Ans: The Treatment and Prevention of Herpes Labialis Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Treatment and Prevention of Herpes Labialis Market size in 2031?

Ans: The Treatment and Prevention of Herpes Labialis Market size in 2031 will be US$ 1715 million.

Who are the main players in the Treatment and Prevention of Herpes Labialis Market report?

Ans: The main players in the Treatment and Prevention of Herpes Labialis Market are GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Luoxin, Med shine, Bayer(Campho Phenique), Blistex, Kelun Group, Hikma, Haiwang, Carmex, Cipher

What are the Application segmentation covered in the Treatment and Prevention of Herpes Labialis Market report?

Ans: The Applications covered in the Treatment and Prevention of Herpes Labialis Market report are External Use, Oral, Injection

What are the Type segmentation covered in the Treatment and Prevention of Herpes Labialis Market report?

Ans: The Types covered in the Treatment and Prevention of Herpes Labialis Market report are Valacyclovir, Aciclovir, Famciclovir, Docosanol, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Valacyclovir

1.2.3 Aciclovir

1.2.4 Famciclovir

1.2.5 Docosanol

1.2.6 Other

1.3 Market by Application

1.3.1 Global Treatment and Prevention of Herpes Labialis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Treatment and Prevention of Herpes Labialis Market Perspective (2020-2031)

2.2 Global Treatment and Prevention of Herpes Labialis Growth Trends by Region

2.2.1 Global Treatment and Prevention of Herpes Labialis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Treatment and Prevention of Herpes Labialis Historic Market Size by Region (2020-2025)

2.2.3 Treatment and Prevention of Herpes Labialis Forecasted Market Size by Region (2026-2031)

2.3 Treatment and Prevention of Herpes Labialis Market Dynamics

2.3.1 Treatment and Prevention of Herpes Labialis Industry Trends

2.3.2 Treatment and Prevention of Herpes Labialis Market Drivers

2.3.3 Treatment and Prevention of Herpes Labialis Market Challenges

2.3.4 Treatment and Prevention of Herpes Labialis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue

3.1.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue (2020-2025)

3.1.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Players (2020-2025)

3.2 Global Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Treatment and Prevention of Herpes Labialis Revenue

3.4 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio

3.4.1 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Treatment and Prevention of Herpes Labialis Revenue in 2024

3.5 Global Key Players of Treatment and Prevention of Herpes Labialis Head office and Area Served

3.6 Global Key Players of Treatment and Prevention of Herpes Labialis, Product and Application

3.7 Global Key Players of Treatment and Prevention of Herpes Labialis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Treatment and Prevention of Herpes Labialis Breakdown Data by Type

4.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Type (2020-2025)

4.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2026-2031)

5 Treatment and Prevention of Herpes Labialis Breakdown Data by Application

5.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Application (2020-2025)

5.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Treatment and Prevention of Herpes Labialis Market Size (2020-2031)

6.2 North America Treatment and Prevention of Herpes Labialis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025)

6.4 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Treatment and Prevention of Herpes Labialis Market Size (2020-2031)

7.2 Europe Treatment and Prevention of Herpes Labialis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025)

7.4 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size (2020-2031)

8.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2020-2025)

8.4 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Treatment and Prevention of Herpes Labialis Market Size (2020-2031)

9.2 Latin America Treatment and Prevention of Herpes Labialis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025)

9.4 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size (2020-2031)

10.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025)

10.4 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Treatment and Prevention of Herpes Labialis Introduction

11.1.4 GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.1.5 GSK Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Treatment and Prevention of Herpes Labialis Introduction

11.2.4 Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Treatment and Prevention of Herpes Labialis Introduction

11.3.4 Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.3.5 Teva Recent Development

11.4 Mylan

11.4.1 Mylan Company Details

11.4.2 Mylan Business Overview

11.4.3 Mylan Treatment and Prevention of Herpes Labialis Introduction

11.4.4 Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.4.5 Mylan Recent Development

11.5 Cadila

11.5.1 Cadila Company Details

11.5.2 Cadila Business Overview

11.5.3 Cadila Treatment and Prevention of Herpes Labialis Introduction

11.5.4 Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.5.5 Cadila Recent Development

11.6 Apotex

11.6.1 Apotex Company Details

11.6.2 Apotex Business Overview

11.6.3 Apotex Treatment and Prevention of Herpes Labialis Introduction

11.6.4 Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.6.5 Apotex Recent Development

11.7 Daewoong Pharmaceutical

11.7.1 Daewoong Pharmaceutical Company Details

11.7.2 Daewoong Pharmaceutical Business Overview

11.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Introduction

11.7.4 Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.7.5 Daewoong Pharmaceutical Recent Development

11.8 Livzon

11.8.1 Livzon Company Details

11.8.2 Livzon Business Overview

11.8.3 Livzon Treatment and Prevention of Herpes Labialis Introduction

11.8.4 Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.8.5 Livzon Recent Development

11.9 Luoxin

11.9.1 Luoxin Company Details

11.9.2 Luoxin Business Overview

11.9.3 Luoxin Treatment and Prevention of Herpes Labialis Introduction

11.9.4 Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.9.5 Luoxin Recent Development

11.10 Med shine

11.10.1 Med shine Company Details

11.10.2 Med shine Business Overview

11.10.3 Med shine Treatment and Prevention of Herpes Labialis Introduction

11.10.4 Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.10.5 Med shine Recent Development

11.11 Bayer(Campho Phenique)

11.11.1 Bayer(Campho Phenique) Company Details

11.11.2 Bayer(Campho Phenique) Business Overview

11.11.3 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Introduction

11.11.4 Bayer(Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.11.5 Bayer(Campho Phenique) Recent Development

11.12 Blistex

11.12.1 Blistex Company Details

11.12.2 Blistex Business Overview

11.12.3 Blistex Treatment and Prevention of Herpes Labialis Introduction

11.12.4 Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.12.5 Blistex Recent Development

11.13 Kelun Group

11.13.1 Kelun Group Company Details

11.13.2 Kelun Group Business Overview

11.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Introduction

11.13.4 Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.13.5 Kelun Group Recent Development

11.14 Hikma

11.14.1 Hikma Company Details

11.14.2 Hikma Business Overview

11.14.3 Hikma Treatment and Prevention of Herpes Labialis Introduction

11.14.4 Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.14.5 Hikma Recent Development

11.15 Haiwang

11.15.1 Haiwang Company Details

11.15.2 Haiwang Business Overview

11.15.3 Haiwang Treatment and Prevention of Herpes Labialis Introduction

11.15.4 Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.15.5 Haiwang Recent Development

11.16 Carmex

11.16.1 Carmex Company Details

11.16.2 Carmex Business Overview

11.16.3 Carmex Treatment and Prevention of Herpes Labialis Introduction

11.16.4 Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.16.5 Carmex Recent Development

11.17 Cipher

11.17.1 Cipher Company Details

11.17.2 Cipher Business Overview

11.17.3 Cipher Treatment and Prevention of Herpes Labialis Introduction

11.17.4 Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025)

11.17.5 Cipher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Daewoong Pharmaceutical

LIVZON

Luoxin

Med shine

Bayer (Campho Phenique)

List of Tables

Table 1. Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Valacyclovir

Table 3. Key Players of Aciclovir

Table 4. Key Players of Famciclovir

Table 5. Key Players of Docosanol

Table 6. Key Players of Other

Table 7. Global Treatment and Prevention of Herpes Labialis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Treatment and Prevention of Herpes Labialis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Treatment and Prevention of Herpes Labialis Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Treatment and Prevention of Herpes Labialis Market Share by Region (2020-2025)

Table 11. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Treatment and Prevention of Herpes Labialis Market Share by Region (2026-2031)

Table 13. Treatment and Prevention of Herpes Labialis Market Trends

Table 14. Treatment and Prevention of Herpes Labialis Market Drivers

Table 15. Treatment and Prevention of Herpes Labialis Market Challenges

Table 16. Treatment and Prevention of Herpes Labialis Market Restraints

Table 17. Global Treatment and Prevention of Herpes Labialis Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Treatment and Prevention of Herpes Labialis Market Share by Players (2020-2025)

Table 19. Global Top Treatment and Prevention of Herpes Labialis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2024)

Table 20. Ranking of Global Top Treatment and Prevention of Herpes Labialis Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Treatment and Prevention of Herpes Labialis Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Treatment and Prevention of Herpes Labialis, Headquarters and Area Served

Table 23. Global Key Players of Treatment and Prevention of Herpes Labialis, Product and Application

Table 24. Global Key Players of Treatment and Prevention of Herpes Labialis, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Treatment and Prevention of Herpes Labialis Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2020-2025)

Table 28. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2026-2031)

Table 30. Global Treatment and Prevention of Herpes Labialis Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2020-2025)

Table 32. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2026-2031)

Table 34. North America Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2026-2031) & (US$ Million)

Table 49. GSK Company Details

Table 50. GSK Business Overview

Table 51. GSK Treatment and Prevention of Herpes Labialis Product

Table 52. GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 53. GSK Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Treatment and Prevention of Herpes Labialis Product

Table 57. Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Teva Company Details

Table 60. Teva Business Overview

Table 61. Teva Treatment and Prevention of Herpes Labialis Product

Table 62. Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 63. Teva Recent Development

Table 64. Mylan Company Details

Table 65. Mylan Business Overview

Table 66. Mylan Treatment and Prevention of Herpes Labialis Product

Table 67. Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 68. Mylan Recent Development

Table 69. Cadila Company Details

Table 70. Cadila Business Overview

Table 71. Cadila Treatment and Prevention of Herpes Labialis Product

Table 72. Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 73. Cadila Recent Development

Table 74. Apotex Company Details

Table 75. Apotex Business Overview

Table 76. Apotex Treatment and Prevention of Herpes Labialis Product

Table 77. Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 78. Apotex Recent Development

Table 79. Daewoong Pharmaceutical Company Details

Table 80. Daewoong Pharmaceutical Business Overview

Table 81. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product

Table 82. Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 83. Daewoong Pharmaceutical Recent Development

Table 84. Livzon Company Details

Table 85. Livzon Business Overview

Table 86. Livzon Treatment and Prevention of Herpes Labialis Product

Table 87. Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 88. Livzon Recent Development

Table 89. Luoxin Company Details

Table 90. Luoxin Business Overview

Table 91. Luoxin Treatment and Prevention of Herpes Labialis Product

Table 92. Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 93. Luoxin Recent Development

Table 94. Med shine Company Details

Table 95. Med shine Business Overview

Table 96. Med shine Treatment and Prevention of Herpes Labialis Product

Table 97. Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 98. Med shine Recent Development

Table 99. Bayer(Campho Phenique) Company Details

Table 100. Bayer(Campho Phenique) Business Overview

Table 101. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Product

Table 102. Bayer(Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 103. Bayer(Campho Phenique) Recent Development

Table 104. Blistex Company Details

Table 105. Blistex Business Overview

Table 106. Blistex Treatment and Prevention of Herpes Labialis Product

Table 107. Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 108. Blistex Recent Development

Table 109. Kelun Group Company Details

Table 110. Kelun Group Business Overview

Table 111. Kelun Group Treatment and Prevention of Herpes Labialis Product

Table 112. Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 113. Kelun Group Recent Development

Table 114. Hikma Company Details

Table 115. Hikma Business Overview

Table 116. Hikma Treatment and Prevention of Herpes Labialis Product

Table 117. Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 118. Hikma Recent Development

Table 119. Haiwang Company Details

Table 120. Haiwang Business Overview

Table 121. Haiwang Treatment and Prevention of Herpes Labialis Product

Table 122. Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 123. Haiwang Recent Development

Table 124. Carmex Company Details

Table 125. Carmex Business Overview

Table 126. Carmex Treatment and Prevention of Herpes Labialis Product

Table 127. Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 128. Carmex Recent Development

Table 129. Cipher Company Details

Table 130. Cipher Business Overview

Table 131. Cipher Treatment and Prevention of Herpes Labialis Product

Table 132. Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2020-2025) & (US$ Million)

Table 133. Cipher Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Treatment and Prevention of Herpes Labialis Picture

Figure 2. Global Treatment and Prevention of Herpes Labialis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Treatment and Prevention of Herpes Labialis Market Share by Type: 2024 VS 2031

Figure 4. Valacyclovir Features

Figure 5. Aciclovir Features

Figure 6. Famciclovir Features

Figure 7. Docosanol Features

Figure 8. Other Features

Figure 9. Global Treatment and Prevention of Herpes Labialis Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Treatment and Prevention of Herpes Labialis Market Share by Application: 2024 VS 2031

Figure 11. External Use Case Studies

Figure 12. Oral Case Studies

Figure 13. Injection Case Studies

Figure 14. Treatment and Prevention of Herpes Labialis Report Years Considered

Figure 15. Global Treatment and Prevention of Herpes Labialis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Treatment and Prevention of Herpes Labialis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Treatment and Prevention of Herpes Labialis Market Share by Region: 2024 VS 2031

Figure 18. Global Treatment and Prevention of Herpes Labialis Market Share by Players in 2024

Figure 19. Global Top Treatment and Prevention of Herpes Labialis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Treatment and Prevention of Herpes Labialis Revenue in 2024

Figure 21. North America Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Treatment and Prevention of Herpes Labialis Market Share by Country (2020-2031)

Figure 23. United States Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Treatment and Prevention of Herpes Labialis Market Share by Country (2020-2031)

Figure 27. Germany Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Treatment and Prevention of Herpes Labialis Market Share by Region (2020-2031)

Figure 35. China Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Treatment and Prevention of Herpes Labialis Market Share by Country (2020-2031)

Figure 43. Mexico Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Share by Country (2020-2031)

Figure 47. Turkey Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. GSK Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 52. Teva Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 53. Mylan Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 54. Cadila Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 55. Apotex Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 56. Daewoong Pharmaceutical Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 57. Livzon Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 58. Luoxin Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 59. Med shine Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 60. Bayer(Campho Phenique) Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 61. Blistex Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 62. Kelun Group Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 63. Hikma Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 64. Haiwang Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 65. Carmex Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 66. Cipher Revenue Growth Rate in Treatment and Prevention of Herpes Labialis Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4U20267

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-16R16865

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-3F17301

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4B20221

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Treatment and Prevention of Herpes Labialis Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-8R7932

Global Treatment and Prevention of Herpes Labialis Market Research Report 2025

FEATURED COMPANIES

Treatment and Prevention of Herpes Labialis Market Size

Treatment and Prevention of Herpes Labialis Market

Scope of Treatment and Prevention of Herpes Labialis Market Report

Chapter Outline

FAQ for this report

How fast is Treatment and Prevention of Herpes Labialis Market growing?

What is the Treatment and Prevention of Herpes Labialis Market size in 2031?

Who are the main players in the Treatment and Prevention of Herpes Labialis Market report?

What are the Application segmentation covered in the Treatment and Prevention of Herpes Labialis Market report?

What are the Type segmentation covered in the Treatment and Prevention of Herpes Labialis Market report?

FEATURED COMPANIES

RELATED REPORTS